551 related articles for article (PubMed ID: 24890253)
21. [Detection of pncA mutation associated with pyrazinamide resistance in Mycobacterium tuberculosis by high-resolution melting cure analysis].
Hong CY; Wang F; Liu XL
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):198-201. PubMed ID: 23856143
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous identification and typing of multi-drug-resistant Mycobacterium tuberculosis isolates by analysis of pncA and rpoB.
Brown TJ; Tansel Ö; French GL
J Med Microbiol; 2000 Jul; 49(7):651-656. PubMed ID: 10882091
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
Al-Mutairi NM; Ahmad S; Mokaddas EM
Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
[TBL] [Abstract][Full Text] [Related]
24. Characterization of pncA gene mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Mexico.
Cuevas-Córdoba B; Xochihua-González SO; Cuellar A; Fuentes-Domínguez J; Zenteno-Cuevas R
Infect Genet Evol; 2013 Oct; 19():330-4. PubMed ID: 23321280
[TBL] [Abstract][Full Text] [Related]
25. Pyrazinamide resistance and pncA mutations in drug resistant Mycobacterium tuberculosis clinical isolates from Myanmar.
Ei PW; Mon AS; Htwe MM; Win SM; Aye KT; San LL; Zaw NN; Nyunt WW; Myint Z; Lee JS; Aung WW
Tuberculosis (Edinb); 2020 Dec; 125():102013. PubMed ID: 33142220
[TBL] [Abstract][Full Text] [Related]
26. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.
Melzer M; Gupta N; Petersen I; Cook S; Hall B
Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460
[TBL] [Abstract][Full Text] [Related]
27. Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates.
Mphahlele M; Syre H; Valvatne H; Stavrum R; Mannsåker T; Muthivhi T; Weyer K; Fourie PB; Grewal HM
J Clin Microbiol; 2008 Oct; 46(10):3459-64. PubMed ID: 18753350
[TBL] [Abstract][Full Text] [Related]
28. Spoligotyping with pncA sequencing strategy conferring the transmission of multidrug-resistant tuberculosis in Egypt.
Ismail S; Al Amry K; Aggor G; El Naggar H; Selim S
Int J Mycobacteriol; 2019; 8(3):211-217. PubMed ID: 31512595
[TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates by multiple allele specific polymerase chain reaction in Puducherry, South India.
Thirumurugan R; Kathirvel M; Vallayyachari K; Surendar K; Samrot AV; Muthaiah M
J Infect Public Health; 2015; 8(6):619-25. PubMed ID: 26117709
[TBL] [Abstract][Full Text] [Related]
30. pncA mutations are associated with slower sputum conversion during standard treatment of multidrug-resistant tuberculosis.
Zheng X; Ning Z; Drobniewski F; Yang J; Li Q; Zhang Z; Hu Y
Int J Antimicrob Agents; 2017 Feb; 49(2):183-188. PubMed ID: 28012685
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China.
Xia Q; Zhao LL; Li F; Fan YM; Chen YY; Wu BB; Liu ZW; Pan AZ; Zhu M
Antimicrob Agents Chemother; 2015 Mar; 59(3):1690-5. PubMed ID: 25583712
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
Akhmetova A; Kozhamkulov U; Bismilda V; Chingissova L; Abildaev T; Dymova M; Filipenko M; Ramanculov E
Int J Tuberc Lung Dis; 2015 Feb; 19(2):179-84. PubMed ID: 25574916
[TBL] [Abstract][Full Text] [Related]
33. Real-time PCR followed by high-resolution melting curve analysis: A rapid and pragmatic approach for screening of multidrug-resistant extrapulmonary tuberculosis.
Sharma K; Sharma M; Singh S; Modi M; Sharma A; Ray P; Varma S
Tuberculosis (Edinb); 2017 Sep; 106():56-61. PubMed ID: 28802406
[TBL] [Abstract][Full Text] [Related]
34. Rapid identification of multidrug-resistant Mycobacterium tuberculosis isolates by rpoB gene scanning using high-resolution melting curve PCR analysis.
Pietzka AT; Indra A; Stöger A; Zeinzinger J; Konrad M; Hasenberger P; Allerberger F; Ruppitsch W
J Antimicrob Chemother; 2009 Jun; 63(6):1121-7. PubMed ID: 19369271
[TBL] [Abstract][Full Text] [Related]
35. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide].
Hong CY; Wang F; Gui J; Liu XL
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May; 46(5):436-9. PubMed ID: 22883731
[TBL] [Abstract][Full Text] [Related]
36. Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan.
Ando H; Mitarai S; Kondo Y; Suetake T; Sekiguchi JI; Kato S; Mori T; Kirikae T
Clin Microbiol Infect; 2010 Aug; 16(8):1164-8. PubMed ID: 19832709
[TBL] [Abstract][Full Text] [Related]
37. pncA gene mutations in reporting pyrazinamide resistance among the MDR-TB suspects.
Wu X; Lu W; Shao Y; Song H; Li G; Li Y; Zhu L; Chen C
Infect Genet Evol; 2019 Aug; 72():147-150. PubMed ID: 30447296
[TBL] [Abstract][Full Text] [Related]
38. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
[TBL] [Abstract][Full Text] [Related]
39. Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective.
Perdigão J; Macedo R; João I; Fernandes E; Brum L; Portugal I
Microb Drug Resist; 2008 Jun; 14(2):133-43. PubMed ID: 18573039
[TBL] [Abstract][Full Text] [Related]
40. Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda.
Ssengooba W; Meehan CJ; Lukoye D; Kasule GW; Musisi K; Joloba ML; Cobelens FG; de Jong BC
Infect Genet Evol; 2016 Jun; 40():8-16. PubMed ID: 26917365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
